Lv53
908 积分 2024-09-19 加入
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
31分钟前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
5天前
已完结
Current approaches to the management of brain metastases
8天前
已完结
[Expert consensus on the treatment of advanced lung cancer in elderly patients (2025 edition)]
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
1个月前
已完结
Osimertinib in a patient with end-stage kidney disease not on hemodialysis
1个月前
已完结
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial
2个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
2个月前
已完结
皖公网安备34019202002308
